M.S. in social policy, University of Pennsylvania; B.A. in cultural anthropology, University of Pennsylvania
This researcher is available for interviews.
To arrange an interview, contact RAND Europe Media Relations at +44 (1223) 353 329, x2560, or email europeanmedia@rand.org.
More ExpertsSarah Parkinson is a senior analyst at RAND Europe in the health and wellbeing group. Her interests lie in infectious diseases, antimicrobial resistance (AMR) and surveillance, as well as health innovation and substance use. Her recent work includes a study looking at gaps in pathogen surveillance, which identified ways to strengthen the ability to conduct real-time, integrated surveillance across settings. Other recent studies include a future-proofing study of the EU AMR Action Plan and a study for the Dutch government on the financial ecosystem for medicines research and development and how to make it more fit for the future. She has also conducted studies for ECDC on automated technologies for evidence synthesis and on using point of care testing, electronic health records and digital technologies for infectious disease surveillance. She is currently managing RAND Europe’s evaluation of investment in the treatment and recovery system in England through the government’s 10-year drug strategy, and her previous work looked at prescription opioids in the U.S.
Sarah has extensive experience managing and leading studies, and conducting desk research, interviews, focus groups, workshops and quantitative and qualitative analysis. She holds an M.Sc. in social policy from the University of Pennsylvania, and a B.A. in cultural anthropology from the same university.
